Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up of the TAM-01 Study, a Phase III Trial of Low-dose Tamoxifen, and Pooled Analysis of Three Studies in Breast DCIS, High-risk Lesions and Microinvasive Disease

NCT06982313 is registered in ClinicalTrials.gov with Ente Ospedaliero Ospedali Galliera as lead sponsor.

NCT NCT06982313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06982313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up of the TAM-01 Study, a Phase III Trial of Low-dose Tamoxifen, and Pooled Analysis of Three Studies in Breast DCIS, High-risk Lesions and Microinvasive Disease
Lead sponsor
Ente Ospedaliero Ospedali Galliera
Phase
Observational
Overall status
Completed
Start date
July 1, 1996
Completion date
March 8, 2026
Enrollment
1,545 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer invasive